Pulmonary infection

December 2003
Thorax;Dec2003 Supplement 3, Vol. 58, piii33
Academic Journal
Community acquired pneumonia (CAP) is associated with a high in-patient burden. The Pneumonia Severity Index and Confusion, Urea, Respiratory Rate, Blood Pressure (CURB)-652 identifies those suitable for out-patient treatment (OPT). This retrospective study of patients admitted with CAP compares two scoring systems in identifying those appropriate for OPT, short in-patient stay (SIPS) or high-risk requiring ITU care. CAP in the elderly is associated with high mortality. The CURB criteria for CAP severity are less specific and sensitive for older patients in predicting mortality than in younger patients. However they remain useful and identified 81% of those who died.


Related Articles

  • Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Steer, J.; Norman, E. M.; Afolabi, O. A.; Gibson, G. J.; Bourke, S. C. // Thorax;Feb2012, Vol. 67 Issue 2, p117 

    Background Rates of mortality and readmission are high in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). In this population, the prognostic value of the Medical Research Council Dyspnoea Scale (MRCD) is uncertain, and an extended MRCD (eMRCD)...

  • Doubt over steroids in COPD. Praities, Nigel // Pulse;12/3/2008, Vol. 68 Issue 42, p10 

    The article reports on the study on the routine use of inhaled steroids in patients with Chronic Obstructive Pulmonary Disease (COPD). It shows that steroids had no significant effect on all-cause mortality, but increased the risk of pneumonia by 34%. Furthermore, researchers warned that...

  • Increased Long-Term Mortality after an Episode of Community-Acquired Pneumonia--Time to Move beyond Descriptive Studies. Marrie, Thomas J.; Michelakis, Evangelos // Clinical Infectious Diseases;12/15/2003, Vol. 37 Issue 12, p1625 

    This article reports the results of an analysis of factors associated with long-term mortality in patients who survived 90 days after presentation to the hospital with community-acquired pneumonia (CAP). A case-control method was used to determine whether there was increased long-term mortality...

  • Severity assessment in community-acquired pneumonia: moving on. Wei Shen Lim // Thorax;Apr2007, Vol. 62 Issue 4, p287 

    The author reflects on the severity assessment tools in managing community-acquired pneumonia (CAP). He points that the use Pneumonia Severity Index is a well establishment tool to assess patients with CAP. He also recognizes the use of CURB65, which take account on the presence of confusion,...

  • A Clinical Comparison of Slow- and Rapid-Escalation Treprostinil Dosing Regimens in Patients with Pulmonary Hypertension. Skoro-Sajer, Nika; Lang, Irene M.; Harja, Evis; Kneussl, Meinhard P.; Sing, Wendy Gin; Gibbs, Simon J. R. // Clinical Pharmacokinetics;2008, Vol. 47 Issue 9, p611 

    Background and objective: Subcutaneous treprostinil is an effective treatment for pulmonary arterial hypertension (PAH). A previous pivotal study indicated that infusion site pain was dose dependent and resulted in suboptimal dose escalation by week 12 and a reduced clinical benefit. We...

  • Impact of ventilator associated pneumonia on outcome in patients with chronic obstructive pulmonary disease exacerbation. Hadda, Vijay; Khilnani, Gopi Chand; Dubey, Gajendra; Nallan, Rajkanna; Kumar, Guresh; Guleria, Randeep // Lung India;Jan-Mar2014, Vol. 31 Issue 1, p4 

    Background and Objective: There are sparse data regarding the impact of ventilator-associated pneumonia (VAP) on outcome among patients with chronic obstructive pulmonary disease (COPD) exacerbation. Materials and Methods: This retrospective study included patients with COPD exacerbation...

  • Healthcare-Associated Pneumonia in the Intensive Care Unit. Kollef, Marin H. // Current Medical Literature: Respiratory Medicine;2009, Vol. 23 Issue 1, p1 

    The article offers information on healthcare-associated pneumonia (HCAP) which requires treatment in the intensive care unit (ICU). It states that patients with HCAP have specific risk factors for multidrug-resistant (MDR) infection. It mentions that patients with HCAP differ from those with...

  • Ventilator-Associated Pneumonia--The Wrong Quality Measure for Benchmarking. Klompas, Michael; Platt, Richard // Annals of Internal Medicine;12/4/2007, Vol. 147 Issue 11, p803 

    Legislators, payers, and quality-of-care advocates across the United States are considering requiring hospitals to report ventilator-associated pneumonia rates as a way to benchmark and reward quality of care. Accurate diagnosis of ventilator-associated pneumonia, however, is notoriously...

  • Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia. Miyashita, Naoyuki; Akaike, Hiroto; Teranishi, Hideto; Kawai, Yasuhiro; Ouchi, Kazunobu; Kato, Tadashi; Hayashi, Toshikiyo; Okimoto, Niro // Journal of Infection & Chemotherapy;Apr2013, Vol. 19 Issue 2, p249 

    Nursing and healthcare-associated pneumonia (NHCAP) is a new category that is distinct from community-acquired pneumonia that has been documented in the 2011 Japanese Respiratory Society (JRS) guidelines. We aimed to evaluate an ELNAS Plate test for detecting anti- Chlamydophila...


Read the Article


Sign out of this library

Other Topics